Foundation for Prader-Willi Blog

De-Risking Treatment Development: Paving the Way for Therapeutic Successes

The Foundation for Prader-Willi Research (FPWR) employs a "de-risking" funding strategy to accelerate the development of new treatments for Prader-Willi syndrome (PWS). We are here to take the risks, fund new ideas, and help build the resources that ...

November 19, 2024 Read More

Topics: Therapeutic Development, Research, SYS

FPWR Announces 2nd Round of 2024 Grants

We are pleased to announce the recipients of our second round of grants for 2024, totaling $1,681,781 in awards, as part of the Foundation for Prader-Willi Research’s (FPWR) ongoing commitment to advancing research in Prader-Willi syndrome (PWS) and ...

November 13, 2024 Read More

Topics: Research, SYS

FPWR Announces 1st Round of 2024 Grants

We are pleased to announce the recipients of our first round of grants for 2024, totaling more than $1,000,000 in awards, as part of the Foundation for Prader-Willi Research's (FPWR) ongoing commitment to advancing research in Prader-Willi (PWS) and ...

May 15, 2024 Read More

Topics: Research, SYS

Understanding the Impact of Schaaf-Yang Syndrome from Caregiver Insights

Schaaf-Yang syndrome (SYS) is an ultra-rare disorder that was first identified in 2013. It is caused by mutations in the MAGEL2 gene, a gene that is also deleted or inactivated in Prader-Willi syndrome (PWS). Because SYS is a relatively newly describ...

February 21, 2024 Read More

Topics: Research, Parents, SYS

Schaaf-Yang Syndrome Update with Dr. Schaaf [2023 Conference Video]

In this 85‑minute video, Dr. Christian Schaaf, medical director and department chair at the Institute of Human Genetics at the University of Heidelberg and visiting professor at the Baylor College of Medicine, explains our understanding of Schaaf-Yan...

February 16, 2024 Read More

Topics: Research, SYS

FPWR Announces 2nd Round of 2023 Grants

We are pleased to announce the recipients of the second round of grants for 2023, totaling $1,000,000 in awards, as part of the Foundation for Prader-Willi Research's (FPWR) ongoing commitment to advancing research in Prader-Willi (PWS) and Schaaf-Ya...

November 14, 2023 Read More

Topics: Research, SYS

Partnership with CombinedBrain Will Establish Biorepository for PWS & SYS

The Foundation for Prader-Willi Research has partnered with COMBINEDBrain to establish a biorepository of blood and urine samples that will help speed treatments for people with PWS and other neurodevelopmental disorders. Biorepositories play a cruci...

July 19, 2023 Read More

Topics: PWS People, Volunteer, SYS

FPWR-Funded Postdoc Will Investigate the MAGEL2 Gene

Drug development for new therapies begins with research and discovery. To treat PWS (Prader-Willi syndrome) and SYS (Schaaf-Yang syndrome), we need to understand the differences between individuals with these conditions and typical individuals, right...

June 14, 2023 Read More

Topics: Research, SYS

A New Rat Model for the Study of Features Underlying Schaaf-Yang Syndrome

Mice have long been the preferred mammal model in research labs due to their cost, size, and tractable genetics. Their behavioral simplicity, however, limits a researcher’s options for studying the component features that may serve as surrogate measu...

May 9, 2023 Read More

Topics: Research, SYS

Foundation for Prader-Willi Blog | SYS

Categories

De-Risking Treatment Development: Paving the Way for Therapeutic Successes

FPWR Announces 2nd Round of 2024 Grants

FPWR Announces 1st Round of 2024 Grants

Understanding the Impact of Schaaf-Yang Syndrome from Caregiver Insights

Schaaf-Yang Syndrome Update with Dr. Schaaf [2023 Conference Video]

FPWR Announces 2nd Round of 2023 Grants

Partnership with CombinedBrain Will Establish Biorepository for PWS & SYS

FPWR-Funded Postdoc Will Investigate the MAGEL2 Gene

A New Rat Model for the Study of Features Underlying Schaaf-Yang Syndrome

About FPWR

Main Menu

Our Mission

Contact Us